Initial Trial Results Indicate Significant Reduction in Operational Cost and Improved Quality of Bio-Diesel With Use of CTis Technology
LOS ANGELES, CA--(Marketwired - Apr 7, 2016) - Cavitation Technologies, Inc. ("CTi") (
The initial results indicate that CTi's technology and process, which was granted a patent by the USPTO in 2013, entitled 'Process for Producing Biodiesel through Lower Molecular Weight Alcohol-Targeted Cavitation', has demonstrated that it can substantially reduce the use of chemicals and associated costs in the production of biodiesel. Working in tandem with strategic partner Desmet Ballestra, the Company intends to initially target North and South American bio-diesel refineries for new facility installations as well as the enhancement and upgrading of older refineries.
Roman Gordon, CTi's CTO commented that, "We certainly believe that this trial provides us with preliminary evidence that our technology has the potential to fill the current and future needs of bio-diesel producers. Refineries such as the one where our Nano Reactor System is currently being utilized are constantly looking for technologies that provide an innovative approach to the reduction of operational costs and improving the quality of bio-diesel. Also, our process allows refineries to use less harsh chemicals, which lessens the environmental impact of the production process."
Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, devices and systems as well as develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement and water treatment. As an add-on to its existing neutralization systems, the company's patented NanoReactor™ is designed to allow refiners to reduce both processing costs and environmental impact, while also increasing yield. More information is available at http://www.ctinanotech.com/.
About Desmet Ballestra Group
The Desmet Ballestra Group provides engineering and supply of plants and equipment for the following industries worldwide:
- Oils and Fats and Animal Feed,
- Detergents, Surfactants and related Chemicals,
- Oleochemical and Biodiesel
Desmet Ballestra's R&D Team is composed of professionals specialized in Oils and Fats, oleochemicals and chemical processes, using the most comprehensive set of technological resources and equipment. Controlled by Financière DSBG, a holding company based in Paris, France, the Desmet Ballestra Group is present in all major market areas of the world through its integrated business units located in Northern and Central America (USA, Mexico), South America (Argentina, Brazil, Colombia), Asia & Far East (PR China, Singapore, Malaysia), India and Europe (Belgium, Turkey, Russia, Spain).
Forward Looking Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions, and include statements regarding the Company's intent to initially target North and South American bio-diesel refineries for new facility installations as well as the enhancement and upgrading of older refineries, the Company's belief that this trial provides us with preliminary evidence that the Company's technology has the potential to fill the current and future needs of bio-diesel producers, the Company's belief that this trial provides us with preliminary evidence that the Company's technology has the potential to fill the current and future needs of bio-diesel producers. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment, the continued success of our relationship with Desmet Ballestra and our ability to perform the installation as anticipated and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Cavitation Technologies, Inc.
Chief Financial Officer
Phone (818) 718-0905